Marmont F, Pich A, Chiusa L, Locatelli F, Falda M, Boccadoro M, Resegotti L
Department of Hematology, S. Giovanni Hospital, Torino, Italy.
Eur J Haematol. 1996 Jan-Feb;56(1-2):39-44. doi: 10.1111/j.1600-0609.1996.tb00291.x.
The correlation between the bromodeoxiuridine (BrdU)-labelling index (LI) of plasma cells and a new proliferation marker, the Argyrophilic Nucleolar Organizer Regions (AgNORs), was investigated in 44 myeloma patients at diagnosis. A preliminary analysis was made to verify the reproducibility of the assessment of plasma cell infiltration (PC%) in bone marrow aspirates, used to collect cells for LI determination, and in bone marrow biopsies, used for AgNORs evaluation. Although an overall good correlation was observed between PC% in biopsies and aspirates (r=0.58, p=0.001), the ratio between PC% in biopsies and in aspirates ranged form 0.35 to 7.5. Only 17 patients (38.6%) were within the 0.5-1.5 range. A positive correlation between LI and AgNORs was observed in these patients (r=0.68, p=0.003), whereas the correlation was lost in patients with higher ratio between PC% in biopsies and in aspirates (r=0.08, p=0.69). The prognostic significance of AgNORs was confirmed by survival analysis, showing a reduced survival for patients with high (>4.4) AgNOR counts (14 months vs 35 months, p=0.004). The AgNORs analysis therefore allows the simultaneous evaluation of myeloma cell infiltration, degree of differentiation and kinetics of growth in bone marrow biopsies. AgNOR counts deserve to be included in the procedures for diagnosis and prognostic evaluation of myeloma patients.
在44例骨髓瘤患者诊断时,研究了浆细胞的溴脱氧尿苷(BrdU)标记指数(LI)与一种新的增殖标志物嗜银核仁组织区(AgNORs)之间的相关性。进行了初步分析,以验证用于收集细胞进行LI测定的骨髓穿刺液和用于AgNORs评估的骨髓活检组织中浆细胞浸润(PC%)评估的可重复性。尽管观察到活检组织和穿刺液中的PC%之间总体具有良好的相关性(r = 0.58,p = 0.001),但活检组织与穿刺液中PC%的比值范围为0.35至7.5。只有17例患者(38.6%)处于0.5 - 1.5范围内。在这些患者中观察到LI与AgNORs之间呈正相关(r = 0.68,p = 0.003),而在活检组织与穿刺液中PC%比值较高的患者中相关性消失(r = 0.08,p = 0.69)。生存分析证实了AgNORs的预后意义,显示AgNOR计数高(>4.4)的患者生存率降低(14个月对35个月,p = 0.004)。因此,AgNORs分析能够同时评估骨髓瘤细胞在骨髓活检组织中的浸润情况、分化程度和生长动力学。AgNOR计数值得纳入骨髓瘤患者的诊断和预后评估程序中。